Fidelity MSCI Health Care Index ETF (FHLC)
| Assets | $2.99B |
| Expense Ratio | 0.08% |
| PE Ratio | 23.82 |
| Shares Out | 45.00M |
| Dividend (ttm) | $0.91 |
| Dividend Yield | 1.38% |
| Ex-Dividend Date | Mar 15, 2024 |
| Payout Ratio | 32.91% |
| 1-Year Return | +5.25% |
| Volume | 80,816 |
| Open | 65.56 |
| Previous Close | 65.77 |
| Day's Range | 65.56 - 66.01 |
| 52-Week Low | 57.32 |
| 52-Week High | 70.01 |
| Beta | n/a |
| Holdings | 372 |
| Inception Date | Oct 21, 2013 |
About FHLC
Fund Home PageThe Fidelity MSCI Health Care Index ETF (FHLC) is an exchange-traded fund that is based on the MSCI US IMI 25/50 Health Care index, a market-cap-weighted index of stocks in the broad US health care sector. FHLC was launched on Oct 21, 2013 and is issued by Fidelity.
Top 10 Holdings
48.82% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.96% |
| UnitedHealth Group Incorporated | UNH | 7.60% |
| Johnson & Johnson | JNJ | 6.03% |
| Merck & Co., Inc. | MRK | 5.42% |
| AbbVie Inc. | ABBV | 4.99% |
| Thermo Fisher Scientific Inc. | TMO | 3.76% |
| Abbott Laboratories | ABT | 3.13% |
| Danaher Corporation | DHR | 2.96% |
| Pfizer Inc. | PFE | 2.50% |
| Amgen Inc. | AMGN | 2.46% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 15, 2024 | $0.238 | Mar 20, 2024 |
| Dec 15, 2023 | $0.224 | Dec 20, 2023 |
| Sep 15, 2023 | $0.219 | Sep 20, 2023 |
| Jun 16, 2023 | $0.229 | Jun 22, 2023 |
| Mar 17, 2023 | $0.232 | Mar 22, 2023 |
| Dec 16, 2022 | $0.194 | Dec 21, 2022 |
News
ETF strategies helped pivot investors ‘away from consumer discretionary tech': Expert
Pacer ETFs President Sean O'Hara joins Yahoo Finance Live anchors Seana Smith and Dave Briggs to weigh in on the state of the ETF market and shares his thoughts on the Fed's approach to tamp down infl...
Health-care ETFs win the week as Biden presidency affirms Obamacare
Health-care exchange-traded funds ticked down fractionally in Friday morning trading, but were still on track to be the top performing sector for the week.
Biotech stocks fall after Trump promises executive order drug prices
CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.
Health-care stocks could rebound after their worst week of the year
Health care's sharp drop comes as investors worry that left-leaning policy ideas like universal health coverage are gaining support.